Published in JAMA on September 09, 1992
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol (1997) 37.26
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol (1995) 15.19
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol (1999) 11.63
Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol (1993) 11.24
Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol (2002) 8.88
An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev (1993) 8.03
Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol (1993) 6.65
Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus". BMJ (1998) 4.79
Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis. J Clin Microbiol (1994) 3.96
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system. J Clin Microbiol (1994) 3.81
Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol (1997) 3.74
Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73
Mixed-linker polymerase chain reaction: a new method for rapid fingerprinting of isolates of the Mycobacterium tuberculosis complex. J Clin Microbiol (1993) 3.20
Evaluation of four DNA typing techniques in epidemiological investigations of bovine tuberculosis. J Clin Microbiol (1998) 2.44
Restriction fragment length polymorphism Mycobacterium tuberculosis strains isolated from Greenland during 1992: evidence of tuberculosis transmission between Greenland and Denmark. J Clin Microbiol (1994) 2.41
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect Immun (1995) 2.08
DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol (1995) 2.04
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol (2001) 1.80
National Tuberculosis Genotyping and Surveillance Network: design and methods. Emerg Infect Dis (2002) 1.78
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep (1993) 1.70
Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries. Bull World Health Organ (1997) 1.50
Transmission of drug-susceptible and drug-resistant tuberculosis and the critical importance of airborne infection control in the era of HIV infection and highly active antiretroviral therapy rollouts. Clin Infect Dis (2010) 1.47
Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis (2005) 1.46
Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis (1996) 1.39
Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol (2004) 1.36
Rationale and methods for the National Tuberculosis Genotyping and Surveillance Network. Emerg Infect Dis (2002) 1.30
Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerg Infect Dis (2003) 1.29
Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR. J Clin Microbiol (1996) 1.24
Nosocomial tuberculosis in India. Emerg Infect Dis (2006) 1.21
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis. J Bacteriol (1996) 1.20
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev (2004) 1.19
Descriptive profile of tuberculin skin testing programs and laboratory-acquired tuberculosis infections in public health laboratories. J Clin Microbiol (1997) 1.19
Transmission dynamics of tuberculosis in a high-incidence country: prospective analysis by PCR DNA fingerprinting. J Clin Microbiol (1999) 1.12
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti. BMC Public Health (2006) 1.11
Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerg Infect Dis (2001) 1.11
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). J Clin Microbiol (1999) 1.09
Molecular epidemiology of Mycobacterium tuberculosis strains isolated from patients in a human immunodeficiency virus cohort in Switzerland. J Clin Microbiol (1997) 1.08
Tuberculosis: 11. Nosocomial disease. CMAJ (1999) 1.07
The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach. Epidemiol Infect (2008) 1.07
In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 1.07
Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare. Antimicrob Agents Chemother (1995) 1.05
Impact of genotyping of Mycobacterium tuberculosis on public health practice in Massachusetts. Emerg Infect Dis (2002) 1.04
Controlling tuberculosis in an urban emergency department: a rapid decision instrument for patient isolation. Am J Public Health (1997) 1.01
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
Molecular epidemiology of tuberculosis in a rural area of high prevalence in South India: implications for disease control and prevention. J Clin Microbiol (2002) 1.00
Aerobiology and its role in the transmission of infectious diseases. J Pathog (2013) 0.97
Tuberculosis and HIV disease: two decades of a dual epidemic. Wien Klin Wochenschr (2003) 0.93
Validity of clinical prediction rules for isolating inpatients with suspected tuberculosis. A systematic review. J Gen Intern Med (2005) 0.91
The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada. Can J Infect Dis Med Microbiol (2007) 0.90
Current approaches to tuberculosis in the United States. JAMA (2012) 0.89
Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. BMC Public Health (2011) 0.89
Comparison of tuberculosis infection control programs in Canadian hospitals categorized by size and risk of exposure to tuberculosis patients, 1989 to 1993 - Part 2. Can J Infect Dis (1997) 0.86
Is the detection of Mycobacterium tuberculosis DNA by ligase chain reaction worth the cost: experiences from an inner London teaching hospital. J Clin Pathol (2000) 0.84
Restriction fragment length polymorphism typing of Mycobacterium tuberculosis. Thorax (1995) 0.82
Status of tuberculosis infection control programs in Canadian acute care hospitals, 1989 to 1993 - Part 1. Can J Infect Dis (1997) 0.81
A high-resolution computed tomography-based scoring system to differentiate the most infectious active pulmonary tuberculosis from community-acquired pneumonia in elderly and non-elderly patients. Eur Radiol (2014) 0.81
Induced sputum is safe and well-tolerated for TB diagnosis in a resource-poor primary healthcare setting. Am J Trop Med Hyg (2014) 0.80
Tuberculosis transmission from healthcare workers to patients and co-workers: a systematic literature review and meta-analysis. PLoS One (2015) 0.78
Tracing patients exposed to health care workers with tuberculosis. Public Health Rep (1997) 0.76
[Tuberculosis as occupational disease]. Rev Peru Med Exp Salud Publica (2012) 0.75
The scourge of tuberculosis revisited. Can J Infect Dis (1995) 0.75
Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru. Am J Trop Med Hyg (2016) 0.75
Resistance to Antituberculosis Drugs in Pulmonary Tuberculosis. Med J Armed Forces India (2011) 0.75
Comparing risk factors for primary multidrug-resistant tuberculosis and primary drug-susceptible tuberculosis in Jiangsu province, China: a matched-pairs case-control study. Am J Trop Med Hyg (2014) 0.75
Infection of great apes and a zoo keeper with the same Mycobacterium tuberculosis spoligotype. Med Microbiol Immunol (2013) 0.75
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol (1993) 45.22
CDC definitions for nosocomial infections, 1988. Am J Infect Control (1988) 27.03
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11
IS6110, an IS-like element of Mycobacterium tuberculosis complex. Nucleic Acids Res (1990) 16.68
Repetitive DNA sequences as probes for Mycobacterium tuberculosis. J Clin Microbiol (1988) 14.26
Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (1999) 13.53
Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis (1990) 13.18
The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol Cell Probes (1991) 10.70
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med (1999) 10.21
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA (1996) 9.45
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control (1999) 8.64
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis (1993) 8.63
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol (1992) 8.28
Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis. J Clin Microbiol (1991) 8.24
Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis (1991) 7.94
Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med (1992) 7.50
Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA (1992) 5.97
Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother (1994) 5.64
Epidemiology of nosocomial fungal infections. Clin Microbiol Rev (1996) 5.03
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group. N Engl J Med (1998) 4.95
Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med (1991) 4.72
Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries. Lancet (1999) 4.64
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA (1996) 4.38
Genetic relatedness among strains of the Mycobacterium tuberculosis complex. Analysis of restriction fragment heterogeneity using cloned DNA probes. Am Rev Respir Dis (1986) 4.13
Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06
Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol (1994) 3.85
Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis (2001) 3.82
The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1994) 3.78
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med (1998) 3.64
Cyclic AMP levels in fibroblasts: relationship to growth rate and contact inhibition of growth. Biochem Biophys Res Commun (1971) 3.58
An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. N Engl J Med (1998) 3.45
Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol (1994) 3.35
Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med (2001) 3.33
Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med (1995) 3.31
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25
Mixed-linker polymerase chain reaction: a new method for rapid fingerprinting of isolates of the Mycobacterium tuberculosis complex. J Clin Microbiol (1993) 3.20
Rapid, amplification-based fingerprinting of Mycobacterium tuberculosis. J Gen Microbiol (1993) 3.19
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
Blood contacts during surgical procedures. JAMA (1991) 3.03
Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med (2001) 3.02
National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control (1991) 3.00
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control (1992) 2.95
Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med (1998) 2.88
Regulation of cell growth by cyclic adenosine 3',5'-monophosphate. Effect of cell density and agents which alter cell growth on cyclic adenosine 3',5'-monophosphate levels in fibroblasts. J Biol Chem (1972) 2.85
Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol (1997) 2.81
The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis (1985) 2.76
A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med (1991) 2.73
Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand. Int J Tuberc Lung Dis (1999) 2.68
Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55
Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ (1991) 2.53
Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med (1983) 2.45
Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45
Type III allergic reaction after infusion of immunoglobulins. Lancet (1990) 2.45
The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (1996) 2.44
A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother (1993) 2.39
How fast is fast enough for clinical laboratory turnaround time? Measurement of the interval between result entry and inquiries for reports. Am J Clin Pathol (1997) 2.36
Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol (1987) 2.31
Isolation of plasmids from mycobacteria. Infect Immun (1979) 2.30
Turnaround times for mycobacterial cultures. J Clin Microbiol (1997) 2.30
A hospital-based prevalence survey of bloodstream infections in febrile patients in Malawi: implications for diagnosis and therapy. J Infect Dis (2000) 2.29
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol (1999) 2.28
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol (1992) 2.23
Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol (1994) 2.20
Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis (1998) 2.15
Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.15
Characterization of an SAV organism and proposal of Mycobacterium triplex sp. nov. J Clin Microbiol (1996) 2.09
Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis. Clin Infect Dis (2000) 2.08
Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol (1990) 2.06
The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuber Lung Dis (1996) 2.06
Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis (1999) 2.05
Surgical-site complications associated with a morphine nerve paste used for postoperative pain control after laminectomy. Infect Control Hosp Epidemiol (1999) 2.03
DNA fingerprinting by infrequent-restriction-site amplification. J Clin Microbiol (1996) 2.01
Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis (1997) 1.96
Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother (1996) 1.92
Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997. Chest (2001) 1.91
Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.90
A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol (2000) 1.86
Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med (1998) 1.85
Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 1.84
EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. The EMERGEncy ID NET Study Group. Ann Emerg Med (1998) 1.82
Biotyping coagulase-negative staphylococci. J Clin Microbiol (1988) 1.82
Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis (2001) 1.81
Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion (2001) 1.81
Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol (1993) 1.78
Differentiation of Mycobacterium tuberculosis and Mycobacterium bovis BCG by a polymerase chain reaction assay. Mol Cell Probes (1991) 1.77
Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Rev Infect Dis (1990) 1.76